e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Aspects of bronchopulmonary dysplasia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
DNase treatment for atelectasis in non-CF pediatric patients
T. Hendriks, M. de Hoog, M. Lequin, J. C. de Jongste, P. J. F. M. Merkus (Rotterdam, The Netherlands)
Source:
Annual Congress 2002 - Aspects of bronchopulmonary dysplasia
Session:
Aspects of bronchopulmonary dysplasia
Session type:
Oral Presentation
Number:
3475
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hendriks, M. de Hoog, M. Lequin, J. C. de Jongste, P. J. F. M. Merkus (Rotterdam, The Netherlands). DNase treatment for atelectasis in non-CF pediatric patients. Eur Respir J 2002; 20: Suppl. 38, 3475
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Immunomodulative therapy in young patients with non-CF bronchiectases exacerbations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Factors associated with the need of intravenous antibiotics in a cohort of adult patients with non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF?
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
The surgical treatment of lung bronchiectasis.
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Time to diagnosis and adherence to guidelines in a large cohort of patients with non-CF bronchiectasis
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Lobar atelectasis in cystic fibrosis and treatment with bronchoscopically administered DNase
Source: Eur Respir J 2003; 22: Suppl. 45, 429s
Year: 2003
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Non invasive ventilation (NIV) assists chest physiotherapy for treatment of patients with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
The evaluation of 239 patients with bronchiectasis who had surgical therapy
Source: Annual Congress 2006 - Surgery for chronic benign disease and management of complications
Year: 2006
Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Challenges in the management of non-CF bronchiectasis
Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis
Year: 2016
Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Paratracheal air cysts in patients with non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Long-term macrolide therapy for non-CF bronchiectasis
Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"
Year: 2013
Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction
Source: Annual Congress 2011 - COPD management
Year: 2011
Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties?
Source: Eur Respir J 2007; 30: Suppl. 51, 374s
Year: 2007
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept